Cortisol and Growth Hormone Secretion in Relation to Linear Growth: Patients with Still's Disease on Different Therapeutic Regimens

Sturge, R. A.; Beardwell, C.; Hartog, M.; Wright, D.; Ansell, B. M.
September 1970
British Medical Journal;9/5/1970, Vol. 3 Issue 5722, p547
Academic Journal
No abstract available.


Related Articles

  • A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease. Kalliolia, Eirini; Silajdžić, Edina; Nambron, Rajasree; Costelloe, Seán J.; Martin, Nicholas G.; Hill, Nathan R.; Frost, Chris; Watt, Hilary C.; Hindmarsh, Peter; Björkqvist, Maria; Warner, Thomas T. // PLoS ONE;10/2/2015, Vol. 10 Issue 10, p1 

    Background: Huntington’s disease is an inherited neurodegenerative disorder characterised by motor, cognitive and psychiatric disturbances. Patients exhibit other symptoms including sleep and mood disturbances, muscle atrophy and weight loss which may be linked to hypothalamic pathology...

  • Growth hormone, insulin, and prolactin secretion in anorexia nervosa and obesity during bromocriptine treatment. Harrower, A.D.B.; Yap, P.L.; Nairn, Isobel M.; Walton, H.J.; Strong, J.A.; Craig, A. // British Medical Journal;7/16/1977, Vol. 2 Issue 6080, p156 

    Measures growth hormone, insulin and prolactin secretion in obese and anorexic patients during bromocriptine treatment. Therapeutic dosage of bromocriptine; Elevation of growth hormone in anorexic patients during oral glucose tolerance test; Decrease growth hormone in obese patients during oral...

  • Changes in cortisol and growth hormone secretion during nocturnal sleep in the course of aging. Kern, Werner; Dodt, Christoph // Journals of Gerontology Series A: Biological Sciences & Medical ;Jan96, Vol. 51A Issue 1, pM3 

    Examines age-related changes in cortisol and growth hormone (GH) secretion during nocturnal sleep. Confirmation of previous findings that elderly humans have less slow wave sleep and less rapid eye movement sleep and diminished nocturnal GH surges; Increase in cortisol nadir concentrations in...

  • Points of integration between the intracellular energy sensor AMP-activated protein kinase (AMPK) activity and the somatotroph axis function. Tulipano, Giovanni; Faggi, Lara; Sibilia, Valeria; Giustina, Andrea // Endocrine (1355008X);Oct2012, Vol. 42 Issue 2, p292 

    AMP-activated protein kinase (AMPK), an enzyme functioning as a cellular sensor of low energy, stores and promotes adaptive changes in growth, differentiation, and metabolism. While AMPK is primarily thought of as a regulator of systemic metabolism, it has been clearly established that it also...

  • First 24 Hours of Acute Pancreatitis. Drew, S. Ian; Joffe, Barry I.; Seftel, Harry; Vinik, Arthur I.; Singer, Fred // American Journal of Gastroenterology;Jul1978, Vol. 70 Issue 1, p66 

    Differences in metabolic homeostasis in 12 patients with initial vs. eight patients with repeated attacks of acute pancreatitis have been compared during the acute phase of the disease. As a group, subjects with a previous history of pancreatitis had significantly lower glucagon concentrations...

  • Antineoplastic Action of Growth Hormone-Releasing Hormone (GHR Antagonists. Siejka, Agnieszka; Lawnicka, Hanna; Melen-Mucha, Gabriela; Motylewska, Ewelina; Komorowski, Jan; Stepien, Henryk // Recent Patents on Anti-Cancer Drug Discovery;Jan2012, Vol. 7 Issue 1, p56 

    Some of the antagonists of growth hormone-releasing hormone (GHRH) are able to inhibit the growth of various experimental human cancers. The antitumor effects of first antagonists seemed to be dependent mainly on the disruption of pituitary secretion of growth hormone (GH), followed by the...

  • Growth-hormone-releasing hormone: a clinical update. Vance, Mary Lee; Thorner, Michael O.; Vance, M L; Thorner, M O // Annals of Internal Medicine;Sep86, Vol. 105 Issue 3, p447 

    Presents information on growth-hormone-releasing hormone (GHRH). Information on the regulation of growth hormone secretion; Discussion of the therapeutic use of GHRH; Details of the therapeutic trials of GHRH.

  • Cancer Vaccines for Hormone/Growth Factor Immune Deprivation:A Feasible Approach for Cancer Treatment. Gonz�lez, G.; Lage, A. // Current Cancer Drug Targets;May2007, Vol. 7 Issue 3, p229 

    One of the older and most validated cancer treatments is endocrine therapy. Some tumors are dependent on hormone stimulation for growth, and therefore therapeutic interventions aiming to deprive the cells of the hormone are feasible and have been successful. Tumor growth also depends in some...

  • Who's for growth hormone? Brook, C.G.D. // BMJ: British Medical Journal (International Edition);1/18/92, Vol. 304 Issue 6820, p131 

    Focuses on the prescription of growth hormones to children with growth disorders in Great Britain. Response of a child to growth hormones; Relation between hormone secretion and rate of growth; Identification of causes for growth disorders.

  • Growth abnormalities in children and adolescents with juvenile idiopathic arthritis. Bechtold, Susanne; Simon, Dominique // Rheumatology International;Nov2014, Vol. 34 Issue 11, p1483 

    In patients with juvenile idiopathic arthritis (JIA) growth impairment and variance in body composition are well-known long-term complications. In the active phases of the disease, particular patients with systemic and polyarticular JIA reveal growth impairment. Some experience 'catch-up' growth...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics